ARCA biopharma (ABIO) Reports Substanital Improvement in Onset of Atrial Fibrillation Using Gencaro
Go back to ARCA biopharma (ABIO) Reports Substanital Improvement in Onset of Atrial Fibrillation Using Gencaro| ARCA BIOPHARMA (NASDAQ: ABIO) | Delayed: 2.40 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.40 | 52 Week High | $6.97 | |||
| Open | $2.40 | 52 Week Low | $2.15 | |||
| Day High | $2.40 | P/E | N/A | |||
| Day Low | $2.40 | EPS | $-1.48 | |||
| Volume | 309,633 | |||||
